News Archive

/static/apps/cms/news/1737/LukacsKunkel.jpg

Opsidio, LLC Acquired by Insmed, Advancing Anti-SCF Therapy: From Discovery to Clinical trials

March 13, 2026 / Research

Opsidio, LLC—co-founded by Nicholas W. Lukacs, PhD, Steven Kunkel, PhD, and Cory Hogaboam, PhD—has been acquired by Insmed, which plans to advance the company’s investigational monoclonal antibody INS1148 into Phase 2 studies for interstitial lung disease and moderate-to-severe asthma.

FULL STORY
/static/apps/cms/news/1577/images/banners/hc1 team header .png

MLabs Supports Department-Wide Implementation of hc1 Platform

September 23, 2024 / Mlabs

Target: Improved Patient Care and Access, Enhanced Efficiency

FULL STORY
/static/apps/cms/news/1334/images/banners/Path-Modern-Age-Header-LG.jpg

Pathology in the Modern Age

October 6, 2022 / Insidepath

The field of Pathology is changing quickly as technology advances, with deep learning and artificial intelligence expanding into diagnostic arenas.

FULL STORY